{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:45:49Z","timestamp":1770338749653,"version":"3.49.0"},"reference-count":55,"publisher":"Bentham Science Publishers Ltd.","issue":"7","funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["NHIR01A1119131"],"award-info":[{"award-number":["NHIR01A1119131"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"CONACyT","doi-asserted-by":"publisher","award":["CB2009-01 No. 134341"],"award-info":[{"award-number":["CB2009-01 No. 134341"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["EMIDDT"],"published-print":{"date-parts":[[2019,10,11]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Natural killer cells (NKC) are a major component of the innate immune response to HCV, mediating their effects through TRAIL and IFN-\u03b3. However, their function is diminished in chronic HCV patients (HCVp). Prolactin is an immunomodulatory hormone capable of activating NKC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective:<\/jats:title><jats:p>The study aims to explore if hyperprolactinemia can activate NKC in HCVp.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>We treated twelve chronic HCVp (confidence level =95%, power =80%) for 15 days with Levosulpiride plus Cimetidine to induce mild hyperprolactinemia. Before and after treatment, we determined TRAIL and NKG2D expression on peripheral blood NKC, along with cytokine profiles, viral loads and liver function. We also evaluated in vitro effects of prolactin and\/or IL-2 on NKC TRAIL or NKG2D expression and IFN-\u03b3 levels on cultured blood mononuclear cells from 8 HCVp and 7 healthy controls.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>The treatment induced mild hyperprolactinemia and increased TRAIL expression on NKC as well as the secretion of IL-1ra, IL-2, PDGF and IFN-\u03b3. Viral loads decreased in six HCVp. IL-2 and TRAIL together explained the viral load decrease. In vitro, prolactin plus IL-2 synergized to increase TRAIL and NKG2D expression on NKC from HCVp but not in controls.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>Levosulpiride\/Cimetidine treatment induced mild hyperprolactinaemia that was associated with NKC activation and Th1-type cytokine profile. Also, an increase in TRAIL and IL-2 was associated with viral load decrease. This treatment could potentially be used to reactivate NKC in HCVp.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1871530319666181206125545","type":"journal-article","created":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T11:07:20Z","timestamp":1544180840000},"page":"975-984","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prolactin Induces IL-2 Associated TRAIL Expression on Natural Killer Cells from Chronic Hepatitis C Patients<i>In vivo<\/i>and<i>In vitro<\/i>"],"prefix":"10.2174","volume":"19","author":[{"given":"Maria L.H.","family":"Medel","sequence":"first","affiliation":[{"name":"Infectology Service, General Hospital of Mexico Dr. \"Eduardo Liceaga\", Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela G.","family":"Reyes","sequence":"additional","affiliation":[{"name":"Liver, Pancreas and Motility Laboratory (HIPAM) - Experimental Medicine Research Unit, Faculty of Medicine, Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luz M.","family":"Porras","sequence":"additional","affiliation":[{"name":"Liver, Pancreas and Motility Laboratory (HIPAM) - Experimental Medicine Research Unit, Faculty of Medicine, Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arturo R.","family":"Bernal","sequence":"additional","affiliation":[{"name":"Directorate of Research, General Hospital of Mexico Dr. Eduardo Liceaga \u201d, Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas S.","family":"Luna","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, IPN Research and Advanced Studies Center, Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adolfo P.","family":"Garcia","sequence":"additional","affiliation":[{"name":"Liver, Pancreas and Motility Laboratory (HIPAM) - Experimental Medicine Research Unit, Faculty of Medicine, Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Cordova","sequence":"additional","affiliation":[{"name":"Directorate of Research, General Hospital of Mexico Dr. Eduardo Liceaga \u201d, Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adalberto","family":"Parra","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, National Institute of Perinatology \u201cIsidro Espinosa de los Reyes \u201d, Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinivas","family":"Mummidi","sequence":"additional","affiliation":[{"name":"South Texas Diabetes & Obesity Institute, School of Medicine, University of Texas Rio Grande Valley, Edinburg, Texas, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Kershenobich","sequence":"additional","affiliation":[{"name":"National Institute of Medical Sciences and Nutrition \u201cSalvador Zubir\u00e1n\u201d, Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josel\u00edn","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Liver, Pancreas and Motility Laboratory (HIPAM) - Experimental Medicine Research Unit, Faculty of Medicine, Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/nrgastro.2016.176","volume":"14","author":"Thrift A.P.","year":"2017","unstructured":"Thrift A.P.; El-Serag H.B.; Kanwal F.; Global epidemiology and burden of HCV infection and HCV-related disease. Nat Rev Gastroenterol Hepatol 2017,14(2),122-132","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"329","DOI":"10.7326\/0003-4819-158-5-201303050-00005","volume":"158","author":"Morgan R.L.","year":"2013","unstructured":"Morgan R.L.; Baack B.; Smith B.D.; Yartel A.; Pitasi M.; Falck-Ytter Y.; Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies. Ann Intern Med 2013,158(5 Pt 1),329-337","journal-title":"Ann Intern Med"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1126\/science.aad1302","volume":"349","author":"Cox A.L.","year":"2015","unstructured":"Cox A.L.; MEDICINE. Global control of hepatitis C virus. Science 2015,349(6250),790-791","journal-title":"Science"},{"key":"ref=4","first-page":"1","volume":"6","author":"Wendt A.","year":"2014","unstructured":"Wendt A.; Adhoute X.; Castellani P.; Oules V.; Ansaldi C.; Benali S.; Bourli\u00e8re M.; Chronic hepatitis C: future treatment. Clin Pharmacol 2014,6,1-17","journal-title":"Clin Pharmacol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nrgastro.2016.60","volume":"13","author":"G\u00f6tte M.","year":"2016","unstructured":"G\u00f6tte M.; Feld J.J.; Direct-acting antiviral agents for hepatitis C: structural and mechanistic insights. Nat Rev Gastroenterol Hepatol 2016,13(6),338-351","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1093\/infdis\/jis762","volume":"207","author":"Lauer G.M.","year":"2013","unstructured":"Lauer G.M.; Immune responses to hepatitis C virus (HCV) infection and the prospects for an effective HCV vaccine or immunotherapies. J Infect Dis 2013,207(Suppl. 1),S7-S12","journal-title":"J Infect Dis"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"7034","DOI":"10.1073\/pnas.0707882105","volume":"105","author":"Sarasin-Filipowicz M.","year":"2008","unstructured":"Sarasin-Filipowicz M.; Oakeley E.J.; Duong F.H.T.; Christen V.; Terracciano L.; Filipowicz W.; Heim M.H.; Interferon signaling and treatment outcome in chronic hepatitis C. Proc Natl Acad Sci USA 2008,105(19),7034-7039","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=8","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/849373","author":"Bellanti F.","year":"2012","unstructured":"Bellanti F.; Vendemiale G.; Altomare E.; Serviddio G.; The impact of interferon lambda 3 gene polymorphism on natural course and treatment of hepatitis C. Clin Dev Immunol 2012","journal-title":"Clin Dev Immunol"},{"key":"ref=9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001092","volume":"8","author":"Suppiah V.","year":"2011","unstructured":"Suppiah V.; Gaudieri S.; Armstrong N.J.; O\u2019Connor K.S.; Berg T.; Weltman M.; Abate M.L.; Spengler U.; Bassendine M.; Dore G.J.; Irving W.L.; Powell E.; Hellard M.; Riordan S.; Matthews G.; Sheridan D.; Nattermann J.; Smedile A.; M\u00fcller T.; Hammond E.; Dunn D.; Negro F.; Bochud P.Y.; Mallal S.; Ahlenstiel G.; Stewart G.J.; George J.; Booth D.R.; International Hepatitis C Genetics Consortium (IHCGC). IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study. PLoS Med 2011,8(9)","journal-title":"PLoS Med"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1159\/000341680","volume":"30","author":"Lunemann S.","year":"2012","unstructured":"Lunemann S.; Schlaphoff V.; Cornberg M.; Wedemeyer H.; NK cells in hepatitis C: role in disease susceptibility and therapy. Dig Dis 2012,30(Suppl. 1),48-54","journal-title":"Dig Dis"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/labinvest.2012.54","volume":"92","author":"Gl\u00e4ssner A.","year":"2012","unstructured":"Gl\u00e4ssner A.; Eisenhardt M.; Kr\u00e4mer B.; K\u00f6rner C.; Coenen M.; Sauerbruch T.; Spengler U.; Nattermann J.; NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner. Lab Invest 2012,92(7),967-977","journal-title":"Lab Invest"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/hep.22715","volume":"49","author":"Ye L.","year":"2009","unstructured":"Ye L.; Wang X.; Wang S.; Wang Y.; Song L.; Hou W.; Zhou L.; Li H.; Ho W.; CD56+ T cells inhibit hepatitis C virus replication in human hepatocytes. Hepatology 2009,49(3),753-762","journal-title":"Hepatology"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.bbadis.2012.09.008","volume":"1832","author":"Gao B.","year":"2013","unstructured":"Gao B.; Radaeva S.; Natural killer and natural killer T cells in liver fibrosis. Biochim Biophys Acta 2013,1832(7),1061-1069","journal-title":"Biochim Biophys Acta"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/hep.24190","volume":"53","author":"Jeong W.I.","year":"2011","unstructured":"Jeong W.I.; Park O.; Suh Y.G.; Byun J.S.; Park S.Y.; Choi E.; Kim J.K.; Ko H.; Wang H.; Miller A.M.; Gao B.; Suppression of innate immunity (natural killer cell\/interferon-\u03b3) in the advanced stages of liver fibrosis in mice. Hepatology 2011,53(4),1342-1351","journal-title":"Hepatology"},{"key":"ref=15","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.05.047","author":"Oliviero B.","unstructured":"Oliviero B.; Varchetta S.; Paudice E.; Michelone G.; Zaramella M.; Mavilio D.; De Filippi F.; Bruno S.; Mondelli M.U.; Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections Gastroenterology, 2009, 137(3), 1151-1160, 1160e1-1160e7","journal-title":"Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections Gastroenterology, 2009, 137(3), 1151-1160, 1160e1-1160e7"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.4049\/jimmunol.1300164","volume":"191","author":"Holder K.A.","year":"2013","unstructured":"Holder K.A.; Stapleton S.N.; Gallant M.E.; Russell R.S.; Grant M.D.; Hepatitis C virus-infected cells downregulate NKp30 and inhibit ex vivo NK cell functions. J Immunol 2013,191(6),3308-3318","journal-title":"J Immunol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1084\/jem.20122235","volume":"209","author":"Benedict C.A.","year":"2012","unstructured":"Benedict C.A.; Ware C.F.; TRAIL: not just for tumors anymore? J Exp Med 2012,209(11),1903-1906","journal-title":"J Exp Med"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1002\/hep.26353","volume":"58","author":"Werner J.M.","year":"2013","unstructured":"Werner J.M.; Heller T.; Gordon A.M.; Sheets A.; Sherker A.H.; Kessler E.; Bean K.S.; Stevens M.; Schmitt J.; Rehermann B.; Innate immune responses in hepatitis C virus-exposed healthcare workers who do not develop acute infection. Hepatology 2013,58(5),1621-1631","journal-title":"Hepatology"},{"key":"ref=19","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.08.066","author":"Ahlenstiel G.","unstructured":"Ahlenstiel G.; Titerence R.H.; Koh C.; Edlich B.; Feld J.J.; Rotman Y.; Ghany M.G.; Hoofnagle J.H.; Liang T.J.; Heller T.; Rehermann B.; Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner Gastroenterology, 2010, 138(1), 325-35e1, 2","journal-title":"Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner Gastroenterology, 2010, 138(1), 325-35e1, 2"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1053\/j.gastro.2010.01.051","volume":"138","author":"Stegmann K.A.","year":"2010","unstructured":"Stegmann K.A.; Bj\u00f6rkstr\u00f6m N.K.; Veber H.; Ciesek S.; Riese P.; Wiegand J.; Hadem J.; Suneetha P.V.; Jaroszewicz J.; Wang C.; Schlaphoff V.; Fytili P.; Cornberg M.; Manns M.P.; Geffers R.; Pietschmann T.; Guzm\u00e1n C.A.; Ljunggren H.G.; Wedemeyer H.; Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection. Gastroenterology 2010,138(5),1885-1897","journal-title":"Gastroenterology"},{"key":"ref=21","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.06.069","author":"Ahlenstiel G.","unstructured":"Ahlenstiel G.; Edlich B.; Hogdal L.J.; Rotman Y.; Noureddin M.; Feld J.J.; Holz L.E.; Titerence R.H.; Liang T.J.; Rehermann B.; Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C Gastroenterology, 2011, 141(4), 1231-1239, 1239e1-1239e2","journal-title":"Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C Gastroenterology, 2011, 141(4), 1231-1239, 1239e1-1239e2"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1172\/JCI38374","volume":"119","author":"Ohira M.","year":"2009","unstructured":"Ohira M.; Ishiyama K.; Tanaka Y.; Doskali M.; Igarashi Y.; Tashiro H.; Hiraga N.; Imamura M.; Sakamoto N.; Asahara T.; Chayama K.; Ohdan H.; Adoptive immunotherapy with liver allograft-derived lymphocytes induces anti-HCV activity after liver transplantation in humans and humanized mice. J Clin Invest 2009,119(11),3226-3235","journal-title":"J Clin Invest"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/hep.21035","volume":"43","author":"Ishiyama K.","year":"2006","unstructured":"Ishiyama K.; Ohdan H.; Ohira M.; Mitsuta H.; Arihiro K.; Asahara T.; Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans. Hepatology 2006,43(2),362-372","journal-title":"Hepatology"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-immunol-020711-075005","volume":"31","author":"Long E.O.","year":"2013","unstructured":"Long E.O.; Kim H.S.; Liu D.; Peterson M.E.; Rajagopalan S.; Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol 2013,31,227-258","journal-title":"Annu Rev Immunol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jprot.2013.06.024","volume":"91","author":"Ma D.","year":"2013","unstructured":"Ma D.; Cao W.; Kapur A.; Felder M.; Scarlett C.O.; Patankar M.S.; Li L.; Differential expression of proteins in na\u00efve and IL-2 stimulated primary human NK cells identified by global proteomic analysis. J Proteomics 2013,91,151-163","journal-title":"J Proteomics"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/NIB-130050","volume":"4","author":"Parra A.","year":"2013","unstructured":"Parra A.; Ram\u00edrez-Peredo J.; Reyes-Mu\u00f1oz E.; Ruiz-Arg\u00fcelles A.; Ruiz-Arg\u00fcelles G.J.A.; Th1-Type Cytokine Named Prolactin. Facts and Hypotheses. Adv Neuroimmune Biol 2013,4,1-6","journal-title":"Adv Neuroimmune Biol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1365-2249.2004.02686.x","volume":"139","author":"Mavoungou E.","year":"2005","unstructured":"Mavoungou E.; Bouyou-Akotet M.K.; Kremsner P.G.; Effects of prolactin and cortisol on natural killer (NK) cell surface expression and function of human natural cytotoxicity receptors (NKp46, NKp44 and NKp30). Clin Exp Immunol 2005,139(2),287-296","journal-title":"Clin Exp Immunol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1002\/jmv.23599","volume":"85","author":"Ishii R.","year":"2013","unstructured":"Ishii R.; Saito T.; Shao L.; Okumoto K.; Nishise Y.; Watanabe H.; Makino N.; Fukao A.; Kitanaka C.; Kayama T.; Ueno Y.; Kawata S.; Serum prolactin levels and prolactin mRNA expression in peripheral blood mononuclear cells in hepatitis C virus infection. J Med Virol 2013,85(7),1199-1205","journal-title":"J Med Virol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/and.12425","volume":"48","author":"El-Serafi A.T.","year":"2016","unstructured":"El-Serafi A.T.; Osama S.; El-Zalat H.; EL-Deen, I.M. Dysregulation of male sex hormones in chronic hepatitis C patients. Andrologia 2016,48(1),82-86","journal-title":"Andrologia"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1677\/joe.1.06007","volume":"185","author":"Kraus M.R.","year":"2005","unstructured":"Kraus M.R.; Sch\u00e4fer A.; Bentink T.; Scheurlen M.; Weissbrich B.; Al-Taie O.; Seufert J.; Sexual dysfunction in males with chronic hepatitis C and antiviral therapy: interferon-induced functional androgen deficiency or depression? J Endocrinol 2005,185(2),345-352","journal-title":"J Endocrinol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"355","DOI":"10.4103\/ijem.IJEM_555_16","volume":"21","author":"Kuchay M.S.","year":"2017","unstructured":"Kuchay M.S.; Mithal A.; Levosulpiride and Serum Prolactin Levels. Indian J Endocrinol Metab 2017,21(2),355-358","journal-title":"Indian J Endocrinol Metab"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3109\/00365529008997622","volume":"25","author":"Tytgat G.N.","year":"1990","unstructured":"Tytgat G.N.; Hameeteman W.; Mulder C.J.; Wiersinga W.; van de Boomgaard D.M.; Dees J.; Five-year cimetidine maintenance trial for peptic ulcer disease. A clinical and endocrinologic approach. Scand J Gastroenterol 1990,25(10),974-980","journal-title":"Scand J Gastroenterol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1200\/JCO.2012.44.3234","volume":"31","author":"Shindoh J.","year":"2013","unstructured":"Shindoh J.; Hasegawa K.; Matsuyama Y.; Inoue Y.; Ishizawa T.; Aoki T.; Sakamoto Y.; Sugawara Y.; Makuuchi M.; Kokudo N.; Low hepatitis C viral load predicts better long-term outcomes in patients undergoing resection of hepatocellular carcinoma irrespective of serologic eradication of hepatitis C virus. J Clin Oncol 2013,31(6),766-773","journal-title":"J Clin Oncol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"R199","DOI":"10.1186\/ar4389","volume":"15","author":"Davis J.M.","year":"2013","unstructured":"Davis J.M.; Knutson K.L.; Strausbauch M.A.; Green A.B.; Crowson C.S.; Therneau T.M.; Matteson E.L.; Gabriel S.E.; Immune response profiling in early rheumatoid arthritis: discovery of a novel interaction of treatment response with viral immunity. Arthritis Res Ther 2013,15(6),R199","journal-title":"Arthritis Res Ther"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1084\/jem.194.10.1395","volume":"194","author":"Thimme R.","year":"2001","unstructured":"Thimme R.; Oldach D.; Chang K.M.; Steiger C.; Ray S.C.; Chisari F.V.; Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 2001,194(10),1395-1406","journal-title":"J Exp Med"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"15661","DOI":"10.1073\/pnas.202608299","volume":"99","author":"Thimme R.","year":"2002","unstructured":"Thimme R.; Bukh J.; Spangenberg H.C.; Wieland S.; Pemberton J.; Steiger C.; Govindarajan S.; Purcell R.H.; Chisari F.V.; Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc Natl Acad Sci USA 2002,99(24),15661-15668","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/imr.12090","volume":"255","author":"Golden-Mason L.","year":"2013","unstructured":"Golden-Mason L.; Rosen H.R.; Natural killer cells: multifaceted players with key roles in hepatitis C immunity. Immunol Rev 2013,255(1),68-81","journal-title":"Immunol Rev"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1136\/gutjnl-2011-300515","volume":"61","author":"Missale G.","year":"2012","unstructured":"Missale G.; Pilli M.; Zerbini A.; Penna A.; Ravanetti L.; Barili V.; Orlandini A.; Molinari A.; Fasano M.; Santantonio T.; Ferrari C.; Lack of full CD8 functional restoration after antiviral treatment for acute and chronic hepatitis C virus infection. Gut 2012,61(7),1076-1084","journal-title":"Gut"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"5673","DOI":"10.4049\/jimmunol.150.12.5673","volume":"150","author":"Gagnerault M.C.","year":"1993","unstructured":"Gagnerault M.C.; Touraine P.; Savino W.; Kelly P.A.; Dardenne M.; Expression of prolactin receptors in murine lymphoid cells in normal and autoimmune situations. J Immunol 1993,150(12),5673-5681","journal-title":"J Immunol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/sj.cr.7290204","volume":"14","author":"Sun R.","year":"2004","unstructured":"Sun R.; Li A.L.; Wei H.M.; Tian Z.G.; Expression of prolactin receptor and response to prolactin stimulation of human NK cell lines. Cell Res 2004,14(1),67-73","journal-title":"Cell Res"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"576","DOI":"10.4049\/jimmunol.163.2.576","volume":"163","author":"Bouchard B.","year":"1999","unstructured":"Bouchard B.; Ormandy C.J.; Di Santo J.P.; Kelly P.A.; Immune system development and function in prolactin receptor-deficient mice. J Immunol 1999,163(2),576-582","journal-title":"J Immunol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jneuroim.2004.11.008","volume":"160","author":"Carre\u00f1o P.C.","year":"2005","unstructured":"Carre\u00f1o P.C.; Saced\u00f3n R.; Jim\u00e9nez E.; Vicente A.; Zapata A.G.; Prolactin affects both survival and differentiation of T-cell progenitors. J Neuroimmunol 2005,160(1-2),135-145","journal-title":"J Neuroimmunol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1749-6632.2000.tb05415.x","volume":"917","author":"Matera L.","year":"2000","unstructured":"Matera L.; Mori M.; Cooperation of pituitary hormone prolactin with interleukin-2 and interleukin-12 on production of interferon-gamma by natural killer and T cells. Ann N Y Acad Sci 2000,917,505-513","journal-title":"Ann N Y Acad Sci"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1440-1711.2004.01201.x","volume":"82","author":"Parra A.","year":"2004","unstructured":"Parra A.; Reyes-Ter\u00e1n G.; Ram\u00edrez-Peredo J.; Jacquemin B.; Quiroz V.; C\u00e1rdenas M.; Garc\u00eda-Sancho M.C.; Larrea F.; Differences in nocturnal basal and rhythmic prolactin secretion in untreated compared to treated HIV-infected men are associated with CD4+ T-lymphocytes. Immunol Cell Biol 2004,82(1),24-31","journal-title":"Immunol Cell Biol"},{"key":"ref=45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075613","volume":"8","author":"Ruiz-Extremera A.","year":"2013","unstructured":"Ruiz-Extremera A.; Mu\u00f1oz-G\u00e1mez J.A.; Abril-Molina A.; Salmer\u00f3n-Ruiz M.A.; Mu\u00f1oz-de-Rueda P.; Pav\u00f3n-Castillero E.J.; Quiles-P\u00e9rez R.; Carazo A.; Gila A.; Jimenez-Ruiz S.M.; Casado J.; Mart\u00edn A.B.; Sanju\u00e1n-N\u00fa\u00f1ez L.; Ocete-Hita E.; Viota J.L.; Le\u00f3n J.; Salmer\u00f3n J.; Variation of transaminases, HCV-RNA levels and Th1\/Th2 cytokine production during the post-partum period in pregnant women with chronic hepatitis C. PLoS One 2013,8(10)","journal-title":"PLoS One"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1097\/MOT.0000000000000024","volume":"18","author":"Nishida S.","year":"2013","unstructured":"Nishida S.; Levi D.M.; Tzakis A.G.; Liver natural killer cell inoculum for liver transplantation with hepatocellular carcinoma. Curr Opin Organ Transplant 2013,18(6),690-694","journal-title":"Curr Opin Organ Transplant"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2165\/00063030-200418060-00006","volume":"18","author":"Malaguarnera M.","year":"2004","unstructured":"Malaguarnera M.; Pistone G.; Neri S.; Romano A.; Brogna A.; Musumeci S.; Interleukin-2 plus ribavirin versus IFN a 2b plus ribavirin in patients with chronic HCV who did not repond to previous IFN a 2b treatment. BioDrugs 2004,18,407-413","journal-title":"BioDrugs"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/liv.12473","volume":"35","author":"Martinez D.","year":"2015","unstructured":"Martinez D.; Palmer C.; Simar D.; Cameron B.A.; Nguyen N.; Aggarwal V.; Lloyd A.R.; Zekry A.; Characterisation of the cytokine milieu associated with the up-regulation of IL-6 and suppressor of cytokine 3 in chronic hepatitis C treatment non-responders. Liver Int 2015,35(2),463-472","journal-title":"Liver Int"},{"key":"ref=49","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.04.037","author":"Patel K.","unstructured":"Patel K.; Remlinger K.S.; Walker T.G.; Leitner P.; Lucas J.E.; Gardner S.D.; McHutchison J.G.; Irving W.; Guha I.N.; Multiplex protein analysis to determine fibrosis stage and progression in patients with chronic hepatitis C Clin Gastroenterol Hepatol, 2014, 12(12), 2113-20e1, 3","journal-title":"Multiplex protein analysis to determine fibrosis stage and progression in patients with chronic hepatitis C Clin Gastroenterol Hepatol, 2014, 12(12), 2113-20e1, 3"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1177\/039463201402700111","volume":"27","author":"Mousa N.","year":"2014","unstructured":"Mousa N.; Eldars W.; Eldegla H.; Fouda O.; Gad Y.; Abousamra N.; Elmasry E.; Arafa M.; Cytokine profiles and hepatic injury in occult hepatitis C versus chronic hepatitis C virus infection. Int J Immunopathol Pharmacol 2014,27(1),87-96","journal-title":"Int J Immunopathol Pharmacol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.cyto.2012.06.003","volume":"60","author":"Sousa G.M.","year":"2012","unstructured":"Sousa G.M.; Oliveira I.S.; Andrade L.J.; Sousa-Atta M.L.; Paran\u00e1 R.; Atta A.M.; Serum levels of Th17 associated cytokines in chronic hepatitis C virus infection. Cytokine 2012,60(1),138-142","journal-title":"Cytokine"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.jhep.2010.06.003","volume":"53","author":"Barnaba V.","year":"2010","unstructured":"Barnaba V.; Hepatitis C virus infection: a \u201cliaison a trois\u201d amongst the virus, the host, and chronic low-level inflammation for human survival. J Hepatol 2010,53(4),752-761","journal-title":"J Hepatol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S0012-1606(03)00210-0","volume":"260","author":"Ain R.","year":"2003","unstructured":"Ain R.; Canham L.N.; Soares M.J.; Gestation stage-dependent intrauterine trophoblast cell invasion in the rat and mouse: novel endocrine phenotype and regulation. Dev Biol 2003,260(1),176-190","journal-title":"Dev Biol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1210\/rp.57.1.435","volume":"57","author":"Yu-Lee L.Y.","year":"2002","unstructured":"Yu-Lee L.Y.; Prolactin modulation of immune and inflammatory responses. Recent Prog Horm Res 2002,57,435-455","journal-title":"Recent Prog Horm Res"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/hep.24628","volume":"55","author":"Edlich B.","year":"2012","unstructured":"Edlich B.; Ahlenstiel G.; Zabaleta Azpiroz A.; Stoltzfus J.; Noureddin M.; Serti E.; Feld J.J.; Liang T.J.; Rotman Y.; Rehermann B.; Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients. Hepatology 2012,55(1),39-48","journal-title":"Hepatology"}],"container-title":["Endocrine, Metabolic &amp; Immune Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/168134","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T22:43:00Z","timestamp":1694472180000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/168134\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,11]]},"references-count":55,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,10,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871530319666181206125545","relation":{},"ISSN":["1871-5303"],"issn-type":[{"value":"1871-5303","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-08-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-15","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}